1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Maccura Biotechnology Co.Ltd
  6. News
  7. Summary
    300463   CNE1000020H3

MACCURA BIOTECHNOLOGY CO.LTD

(300463)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-11
19.34 CNY   +1.04%
07/15Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
06/20Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO
MT
06/10Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO

06/10/2022 | 12:12am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CHINA MERCHANTS SECURITIES CO., LTD. -0.22% 13.84 End-of-day quote.-21.59%
FUTU HOLDINGS LIMITED 0.34% 41.13 Delayed Quote.-5.01%
GUOTAI JUNAN SECURITIES CO., LTD. -0.54% 14.6 End-of-day quote.-18.39%
MACCURA BIOTECHNOLOGY CO.LTD 1.04% 19.34 End-of-day quote.-33.74%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) 0.08% 6.73613 Delayed Quote.6.00%
All news about MACCURA BIOTECHNOLOGY CO.LTD
07/15Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, ..
CI
06/20Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO
MT
06/10Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO
MT
05/13DMaccura Biotechnology Co.Ltd Approves Cash Dividend for 2021, Payable on May 19, 2022
CI
05/11Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2021
CI
04/27Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March..
CI
04/20Maccura Biotechnology Co.Ltd Proposes Final Dividend for the Year 2021
CI
04/19Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December ..
CI
02/17Maccura Biotechnology Nets $246 Million From Private Placement
MT
01/25Maccura Biotechnology Co.Ltd announced that it has received CNY 1.57416 billion in fund..
CI
More news
Financials
Sales 2022 4 190 M 621 M 621 M
Net income 2022 1 090 M 162 M 162 M
Net Debt 2022 - - -
P/E ratio 2022 10,9x
Yield 2022 -
Capitalization 11 845 M 1 757 M 1 757 M
Capi. / Sales 2022 2,83x
Capi. / Sales 2023 2,65x
Nbr of Employees 2 865
Free-Float 59,6%
Chart MACCURA BIOTECHNOLOGY CO.LTD
Duration : Period :
Maccura Biotechnology Co.Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MACCURA BIOTECHNOLOGY CO.LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 19,34 CNY
Average target price 27,83 CNY
Spread / Average Target 43,9%
EPS Revisions
Managers and Directors
Ming Jian Wu General Manager & Director
Qi Lin Liu Chief Financial Officer & Director
Yong Tang Chairman
Yuan Zou Chairman-Supervisory Board
Wan Yi Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MACCURA BIOTECHNOLOGY CO.LTD-33.74%1 757
BIOMÉRIEUX-18.21%12 385
DIASORIN S.P.A.-16.45%7 758
LANTHEUS HOLDINGS, INC.187.82%5 707
10X GENOMICS, INC.-67.62%5 495
NATERA, INC.-40.93%5 349